Absci to Participate in Upcoming Investor Conferences Mar 26, 2025 08:00AM
Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results Mar 18, 2025 04:05PM
Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025 Mar 4, 2025 04:05PM
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Mar 4, 2025 04:00PM
Absci to Participate in the KeyBanc Capital Markets Healthcare Forum Mar 4, 2025 08:00AM
View Older Stories

Feb 18, 2025 08:00AM Absci to Participate in the TD Cowen 45th Annual Health Care Conference
Jan 22, 2025 08:00AM Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference
Jan 10, 2025 07:30AM Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery
Jan 8, 2025 07:01AM Absci Corporation (ABSI) and AMD (AMD) Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery
Jan 8, 2025 07:00AM Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery
Jan 6, 2025 08:00AM Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health
Jan 2, 2025 08:00AM Absci to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Dec 12, 2024 08:00AM Absci Highlights Progress and Updates Across Proprietary Pipeline and Leading AI Platform at 2024 R&D Day
Dec 12, 2024 08:00AM Absci Highlights Progress and Updates Across Proprietary Pipeline and Leading AI Platform at 2024 R&D Day
Nov 21, 2024 08:00AM Absci to Participate in the 36th Annual Piper Sandler Healthcare Conference
Nov 12, 2024 07:30AM Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results
Nov 7, 2024 08:00AM Absci to Host R&D Day on December 12, 2024
Nov 7, 2024 08:00AM Absci to Host R&D Day on December 12, 2024
Oct 31, 2024 08:04AM Absci Corporation (ABSI) and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI
Oct 31, 2024 08:00AM Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI
Oct 24, 2024 08:00AM Absci to Participate in Upcoming Investor Conferences
Oct 15, 2024 08:00AM Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024
Aug 21, 2024 08:00AM Absci to Participate in Upcoming Investor Conferences
Aug 14, 2024 04:01PM Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results
Aug 12, 2024 08:00AM Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI
Jul 10, 2024 08:00AM Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024
Jul 3, 2024 04:00PM Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jun 12, 2024 08:00AM Absci to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit
May 28, 2024 08:00AM Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
May 14, 2024 07:30AM Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results
Apr 16, 2024 08:00AM Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024
Mar 28, 2024 04:05PM Absci to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Mar 21, 2024 07:30AM Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results
Mar 6, 2024 06:34AM Latest Updates of Viva Biotech's Portfolio Companies
Feb 21, 2024 07:30AM Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI
Feb 20, 2024 08:00AM Absci to Participate in Upcoming Investor Conferences
Jan 10, 2024 07:32AM Absci Corporation (ABSI) Appoints Sir Mene Pangalos to its Board
Jan 10, 2024 07:30AM Absci Appoints Professor Sir Mene Pangalos to its Board of Directors
Jan 8, 2024 07:00AM Absci to Present Preclinical Data for ABS-101, A Potential Best-in-Class Anti-TL1A Antibody Development Program, at 42nd Annual J.P. Morgan Healthcare Conference
Jan 3, 2024 08:00AM Absci to Participate in the 26th Annual Needham Growth Conference
Dec 28, 2023 08:00AM Absci to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Dec 20, 2023 07:30AM Absci Corporation (ABSI) and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline
Dec 20, 2023 07:30AM Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline
Dec 20, 2023 07:30AM Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline
Dec 4, 2023 07:30AM Absci Corporation (ABSI) Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate
Dec 4, 2023 07:30AM Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate
Nov 15, 2023 08:00AM Absci to Participate in the Piper Sandler 35th Annual Healthcare Conference
Nov 14, 2023 04:05PM Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results
Nov 14, 2023 06:54AM Almirall and Absci (ABSI) announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases
Nov 14, 2023 02:16AM Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases
Oct 26, 2023 08:00AM Absci to Participate in Upcoming Investor Conferences
Sep 21, 2023 08:00AM Absci Announces Speaker Lineup for Inaugural R&D Day, Including Renowned Global Business Leader Sandi Peterson and VP of Applied Research at NVIDIA Jonathan Cohen
Sep 21, 2023 08:00AM Absci Announces Speaker Lineup for Inaugural R&D Day, Including Renowned Global Business Leader Sandi Peterson and VP of Applied Research at NVIDIA Jonathan Cohen
Sep 6, 2023 08:00AM Absci to Host R&D Day on October 4, 2023
Sep 6, 2023 08:00AM Absci to Host R&D Day on October 4, 2023
View Older Stories